These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24413366)

  • 41. Systemic antibiotic treatment of nosocomial pneumonia.
    Unertl KE; Lenhart FP; Forst H; Peter K
    Intensive Care Med; 1992; 18 Suppl 1():S28-34. PubMed ID: 1640030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotic resistance pattern of bacterial isolates in neonatal care unit.
    Shrestha S; Adhikari N; Rai BK; Shreepaili A
    JNMA J Nepal Med Assoc; 2010; 50(180):277-81. PubMed ID: 22049890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial pressure and the emergence and spread of multiresistant enterococci.
    Rice LB
    Postgrad Med; 2001 Feb; 109(2 Suppl):22-31. PubMed ID: 19667554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of levofloxacin against recent Gram-negative nosocomial pathogens.
    Lanzafame A; Bonfiglio G; Santini L; Mattina R
    Chemotherapy; 2005 Mar; 51(1):44-50. PubMed ID: 15767745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management.
    Kaye KS; Pogue JM
    Pharmacotherapy; 2015 Oct; 35(10):949-62. PubMed ID: 26497481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotics for the acute abdomen.
    Farber MS; Abrams JH
    Surg Clin North Am; 1997 Dec; 77(6):1395-417. PubMed ID: 9431346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nosocomial infections due to gram-negative bacilli in compromised hosts: considerations for prevention and therapy.
    Klastersky J
    Rev Infect Dis; 1985; 7 Suppl 4():S552-8. PubMed ID: 3909312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study on prevalence and molecular mechanisms of antibacterial resistance in Gram-negative pathogens of nosocomial infections in hospitals of Moscow and Perm'].
    Mudrak DE; Ikriannikova LN; Sidorenko SV; Il'ina EN
    Antibiot Khimioter; 2007; 52(7-8):10-6. PubMed ID: 18986019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-lactamase detection in nosocomial bacterial pathogens in Lagos, Nigeria.
    Kesah CN; Odugbemi TO
    Niger Postgrad Med J; 2002 Dec; 9(4):210-3. PubMed ID: 12690681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A guide to antibiotic resistance in bacterial skin infections.
    Perera G; Hay R
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):531-45. PubMed ID: 16164705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC; Johnson DE; Bustamante CI
    Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emergence of resistant microbes in critical care units is transient, despite an unrestricted formulary and multiple antibiotic trials.
    Franklin GA; Moore KB; Snyder JW; Polk HC; Cheadle WG
    Surg Infect (Larchmt); 2002; 3(2):135-44. PubMed ID: 12519480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance drives antibacterial drug development.
    Theuretzbacher U
    Curr Opin Pharmacol; 2011 Oct; 11(5):433-8. PubMed ID: 21862408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in multidrug-resistant gram-negative bacilli and the role of prolonged β-lactam infusion in the intensive care unit.
    Guervil DJ; Chau T
    Crit Care Nurs Q; 2013; 36(4):345-55. PubMed ID: 24002425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit.
    Blot S; Depuydt P; Vogelaers D; Decruyenaere J; De Waele J; Hoste E; Peleman R; Claeys G; Verschraegen G; Colardyn F; Vandewoude K
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):575-9. PubMed ID: 16018434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current perspectives on antibiotic use in the treatment of surgical infections.
    Cheadle WG
    Am J Surg; 1992 Oct; 164(4A Suppl):44S-47S. PubMed ID: 1443360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changing trend of empirical antibiotic regimen: experience of two studies at different periods in a neonatal intensive care unit in Tehran, Iran.
    Marzban A; Samaee H; Mosavinasab N
    Acta Med Iran; 2010; 48(5):312-5. PubMed ID: 21287464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammation and the host response to injury, a large-scale collaborative project: patient-oriented research core--standard operating procedures for clinical care VII--Guidelines for antibiotic administration in severely injured patients.
    West MA; Moore EE; Shapiro MB; Nathens AB; Cuschieri J; Johnson JL; Harbrecht BG; Minei JP; Bankey PE; Maier RV;
    J Trauma; 2008 Dec; 65(6):1511-9. PubMed ID: 19077651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.